Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Sunitinib × Clear all

NCT01164202 2022-03-18

SATURNE

Phase 2/3 Completed

78 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms